bristol-myers glp-1 receptor agonist products agonists in the treatment of type 2 diabetes – state-of-the-art GLP-1 Agonists For Obesity In
Description
Based at Bispebjerg Hospital, Holst was in an ideal location to address the question
Therapeutic options for the management of postprandial glucose in patients with type 2 diabetes on basal insulin
Jungnik A, Arrubla Martinez J, Plum-Mrschel L, Kapitza C, Lamers D, Thamer C, et al
While lifestyle modifications are the cornerstone of PCOS management, pharmacological interventions, including metformin, oral contraceptives, and anti-androgens, are commonly utilized
50 Research has shown that GLP-1 and its related compounds significantly affect these processes in rat fat cells
While GIP has lost most of its insulinotropic activity in patients with T2D, GLP-1 has retained enough of its insulinotropic activity to stimulate insulin secretory responses even in patients with T2D [55]
